Literature DB >> 3397799

Perinatal asphyxia in infants of insulin-dependent diabetic mothers.

F Mimouni1, M Miodovnik, T A Siddiqi, J Khoury, R C Tsang.   

Abstract

Infants of diabetic mothers are thought to be at risk for perinatal asphyxia. We hypothesized that the following are significant risk factors for perinatal asphyxia: poor third-trimester glycemic control, diabetic vascular disease (nephropathy, retinopathy) appearing in pregnancy, pregnancy-associated hypertension, smoking, prematurity, fetal macrosomia, and maternal hyperglycemia and hypoglycemia within 6 hours preceding delivery. We prospectively studied 162 infants born to 149 diabetic mothers (White classes B through R-T). Perinatal asphyxia was defined clinically as fetal distress during labor (late decelerations, persistent fetal bradycardia, or both), 1-minute Apgar score less than or equal to 6, or intrauterine fetal death. Forty-four infants (26.7%) had perinatal asphyxia. The presence of perinatal asphyxia did not correlate with third-trimester glycemic control, pregnancy-associated hypertension, smoking, fetal macrosomia, or maternal hypoglycemia before delivery, but it did correlate significantly with nephropathy appearing in pregnancy, maternal hyperglycemia before delivery, and prematurity. We speculate that (1) the appearance of diabetic vasculopathy (nephropathy) during pregnancy is accompanied by placental vascular disease and subsequently by fetal compromise and (2) in pregnancy complicated by diabetes, maternal and subsequently fetal hyperglycemia before delivery leads to fetal hypoxemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397799     DOI: 10.1016/s0022-3476(88)80282-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Normoblasts in large for gestational age infants.

Authors:  S Dollberg; R Marom; F B Mimouni; M Yeruchimovich
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

2.  Diabetic embryopathy: a developmental perspective from fertilization to adulthood.

Authors:  M Castori
Journal:  Mol Syndromol       Date:  2013-02

Review 3.  The peripartum management of diabetes.

Authors:  Y Yap; A Modi; N Lucas
Journal:  BJA Educ       Date:  2019-11-26

4.  Direct relationship of antepartum glucose control and fetal erythropoietin in human type 1 (insulin-dependent) diabetic pregnancy.

Authors:  J A Widness; K A Teramo; G K Clemons; P Voutilainen; U H Stenman; S M McKinlay; R Schwartz
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

Review 5.  Inpatient management of women with gestational and pregestational diabetes in pregnancy.

Authors:  Etoi A Garrison; Shubhada Jagasia
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

6.  Intrauterine hyperglycemia-induced inflammatory signalling via the receptor for advanced glycation end products in the cardiac muscle of the infants of diabetic mother rats.

Authors:  Ritsuko Kawaharada; Haruna Masuda; Zhenyi Chen; Eric Blough; Tomoko Kohama; Akio Nakamura
Journal:  Eur J Nutr       Date:  2017-09-23       Impact factor: 5.614

7.  High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies.

Authors:  K Teramo; M A Kari; M Eronen; H Markkanen; V Hiilesmaa
Journal:  Diabetologia       Date:  2004-10-22       Impact factor: 10.122

Review 8.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms.

Authors:  Ryan J Van Lieshout; Lakshmi P Voruganti
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

10.  A C. elegans Model for the Study of RAGE-Related Neurodegeneration.

Authors:  Adi Pinkas; Kun He Lee; Pan Chen; Michael Aschner
Journal:  Neurotox Res       Date:  2018-06-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.